Hepatopulmonary syndrome

Liver International

Volumn 24, Issue 5, 2004, Pages 397-401

  Gaines, David I ^a   Fallon, Michael B ^b  

^a University of Alabama at Birmingham   (United States)

^b University of Alabama at Birmingham   (United States)

Author keywords

Cirrhosis; Liver transplantation; Nitric oxide synthase; Pulmonary vasodilatation; Review

Indexed keywords

ACETYLSALICYLIC ACID; INDOMETACIN; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; SOMATOSTATIN DERIVATIVE;

ARTERIAL OXYGEN SATURATION; CHRONIC LIVER DISEASE; CLINICAL FEATURE; CONTRAST ECHOCARDIOGRAPHY; DIFFERENTIAL DIAGNOSIS; DYSPNEA; HEPATOPULMONARY SYNDROME; HUMAN; HYPOXEMIA; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; LUNG BLOOD VESSEL; MORTALITY; OXYGEN THERAPY; REVIEW; SCREENING TEST; VASODILATATION; PATHOPHYSIOLOGY;

HEPATOPULMONARY SYNDROME; HUMANS;

EID: 16644400393     PISSN: 14783223     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2004.0944.x     Document Type: Review

References (24)

1. Sood G, Fallon M B, Niwas S, et al. Utility of a dyspnea-fatigue index for screening liver transplant candidates for hepatopulmonary syndrome (abstract). Hepatology 1998; 28: 2319A.
2. Schenk P, Schonger-Hekele M, Fuhrmann V, Madl C, Silberhumer G, Muller C. Prognostic significance of the hepatopulmonary syndrome in patients with cirrhosis. Gastroenterology 2003; 125: 1042-52.
3. Kaymakoglu S, Kahraman T, Kudat H, Demir K, Cakaloglu Y, Adalet I, Dincer D, et al. Hepatopulmonary syndrome in noncirrhotic portal hypertensive patients. Dig Dis Sci 2003; 48(3): 556-60.
4. Abrahams G A, Jaffe C C, Hoffer P B, Binder H J, Fallon M B. Diagnostic utility of contrast echocardiography and lung perfusion scan in patients with hepatopulmonary syndrome. Gastroenterology 1995; 109: 1283-8.
5. Cremona G, Higenbottam T W, Mayoral V, et al. Elevated exhaled nitric oxide in patients with hepatopulmonary syndrome. Eur Respir J 1995; 8: 1883-5.
6. Rolla G, Brussino L, Colagrande P, et al. Exhaled nitric oxide and oxygenation abnormalities in heriatic cirrhosis. Hepatology 1997; 26: 842-7.
7. Fallon M B, Abrams G A, Luo B, Hou Z, Dai J, Ku D D. The role of endothelial nitric oxide synthase in the pathogenesis of a rat model of hepatopulmonary syndrome. Gastroenterology 1997; 113: 606-14.
8. Nunes H, Lebrec D, Mazmanian M, Capron F, Heller J, Tazi K A, Zerbib E, et al. Role of nitric oxide in hepatopulmonary syndrome in cirrhotic rats. Am J Respir Crit Care Med 2001; 164: 879-85.
9. Carter E P, Hartsfield C L, Miyazono M, Jakkula M, Morris K G Jr., McMurtry I F. Regulation of heme oxygenase-1 by nitric oxide during hepatopulmonary syndrome. Am J Physiol [Lung Cell Mol Physiol] 2002; 283: L346-53.
10. Zhang J, Ling Y, Luo B, Tang L, Stockard C, Grizzle W E, Fallon M E. Analysis of pulmonary heme oxygenase-1 and nitric oxide synthase alterations in experimental hepatopulmonary syndrome. Gastroenterology 2003; 125: 1441-51.
11. Fallon M, Abrams G. Pulmonary dysfunction in chronic liver disease. Hepatology 2000; 32: 859-65.
12. Krowka M J, Porayko M K, Plevak D J, Pappas S C, Steers J L, Krom R A F, Wiener R H. Hepatopulmonary syndrome with progressive hypoxemia as an indication for liver transplantation: case reports and literature review. Mayo Clin Proc 1997; 72: 44-53.
13. Arguendas M, Abrams G A, Krowka M J, Fallon M B. Prospective evaluation of outcomes and predictors of mortality in patients with hepatopulmonary syndrome undergoing liver transplantation. Hepatology 2003; 37: 192-7.
14. Abrams G A, Sanders M K, Fallon M B. Utility of pulse oximetry in the detection of arterial hypoxemia in liver transplant candidates. Liver Transpl 2002; 8: 391-6.
15. Harris E, Kenyon A, Nisbet H, Seelye E, Whitlock R. The normal alveolar-arterial oxygen-tension gradient in man. Clin Sci Mol Med 1974; 46: 89-104.
16. Abrams G, Nanda N, Dubovsky E, Krowka M, Fallon M. Use of macroaggregated albumin lung perfusion scan to diagnose hepatopulmonary syndrome: a new approach. Gastroenterology 1998; 114: 305-10.
17. Abrams G, Fallon M. The hepatopulmonary syndrome. Clin Liver Dis 1997; 1: 185-200.
18. Song J Y, Choi J Y, Ko J T, Bae E J, Kim H S, Noh C I, Yoon Y S. Long-term aspirin therapy for hepatopulmonary syndrome. Pediatrics 1996; 97(6 Part 1): 917-20.
19. Abrams G A, Fallon M B. Treatment of hepatopulmonary syndrome with Allium sativum L. (garlic): a pilot trial. J Clin Gastro 1998; 27: 232-5.
20. Brussino L, Bucca C, Morello M, Scappaticci E, Mauro M, Rolla G. Effect on dyspnoea and hypoxaemia of inhaled NG-nitro-L-arginine methyl ester in hepatopulmonary syndrome. Lancet 2003; 362: 43-4.
21. Rolla G, Bucca C, Brussino L. Methylene blue in the hepatopulmonary syndrome. N Engl J Med 1994; 331: 1098.
22. Schenk P, Madl C, Rezale-Majd S, Lehr S, Muller C. Methylene blue improves the hepatopulmonary syndrome. Ann Int Med 2000; 133: 701-6.
23. Lange PA, Stoller J K. The hepatopulmonary syndrome: effect of liver transplantaion. Clin Chest Med 1996; 17(1): 115-23.
24. Philit F, Wiesendanger T, Gille D, Boillot O, Cordier J. Late resolution of hepatopulmonary syndrome after liver transplantation. Respiration 1997; 64: 173-5.